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Abstract
Background: Whiles awaiting for the arrival of an effective and affordable malaria vaccine, there
is a need to make use of the available control tools to reduce malaria risk, especially in children
under five years and pregnant women. Intermittent preventive treatment (IPT) has recently been
accepted as an important component of the malaria control strategy. This study explored the
potential of a strategy of intermittent preventive treatment for children (IPTC) and timely
treatment of malaria-related febrile illness in the home in reducing the parasite prevalence and
malaria morbidity in young children in a coastal village in Ghana.
Methods: The study combined home-based delivery of IPTC among six to 60 months old and
home treatment of suspected febrile malaria illness within 24 hours. All children between six and
60 months of age received intermittent preventive treatment using amodiaquine and artesunate,
delivered by community assistants every four months (three times in 12 months). Malaria parasite
prevalence surveys were conducted before the first and after the third dose of IPTC.
Results: Parasite prevalence was reduced from 25% to 3% (p < 0.00, Mann-Whitney) one year
after the inception of the two interventions. At baseline, 13.8% of the children were febrile (axillary
temperature greater than or equal to 37.5 degree Celsius) compared to 2.2% at evaluation (post
IPTC3 combined with timely home management of fever) (p < 0.00, Mann-Whitney).
Conclusion: The evaluation result indicates that IPTC given three times in a year combined with
timely treatment of febrile malaria illness, impacts significantly on the parasite prevalence. The
marked reduction in the parasite prevalence with this strategy points to the potential for reducing
malaria-related childhood morbidity and mortality, and this should be explored by control
programme managers.
Background
Malaria is estimated to cause between 300 and 500 mil-
lion clinical cases with about 700,000 to 1.6 million
deaths every year. About 94% of these deaths are believed
to occur in sub-Saharan Africa, which is also the most
resource-limited continent on the globe [1,2]. Malaria
remains a major cause of morbidity and mortality in
Ghana, accounting for over 40% of outpatient clinic visits
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and about 20% of deaths in children under five years of
age [3]. The use of artemisinin-based combination ther-
apy (ACT) for the treatment of uncomplicated falciparum
malaria has been shown to provide effective treatment
against falciparum malaria and slow down the spread of
drug resistance [1]. In line with this recommendation and
the increasing treatment failure rate of chloroquine [4],
the Ghana National Malaria Control Programme,
(GNMCP) has adopted the use of artesunate and amodi-
aquine for the treatment of uncomplicated malaria in the
country since January, 2005. This became necessary
because by 2003 parasitological responses to chloroquine
were less than 50% in some areas of the country. Similar
studies on the efficacy of sulphadoxine/pyrimethamine
(SP) have shown 0-36% of RII resistance and 0-9% of RIII
resistance [5,6].
Malaria control in Ghana relies on early diagnosis and
prompt treatment of suspected cases (fevers) and the
home is where early recognition and, in most cases,
prompt treatment is initiated [7,8]. However, the current
combination therapy is not widely available for home
management. Reluctance to make combination therapy
available for home management results from concerns
that making these drugs widely available may lead to
abuse and, therefore, increased drug pressure on the para-
sites which could lead to the emergence of Plasmodium fal-
ciparum resistance to these anti-malarial drugs, as with
chloroquine and sulphadoxine/pyrimethamine.
Prompt and efficacious treatment of malaria cases is an
effective strategy for malaria control. It is especially
important for vulnerable groups including children under
five years of age and pregnant women. IPT has also
recently been accepted as an important component of the
malaria control strategy following the demonstration, in
perennial malaria transmission areas, that IPT given with
childhood vaccinations reduced incidence of first episode
of malaria. It also reduced severe anaemia by more than
50% during the first year of life [9-11]. IPTC studies were
carried out in areas with seasonal malaria transmission
and were found to be effective [9,12]. The use of bed net
is one of the mainstays of malaria control in Africa and to
promote the use of treated bed net, the Ghana Health
Service has made them available at community levels.
These bed nets were highly subsidized for children under
five years and pregnant women.
Rationale
Although the Abuja target of treating 60% of under-five
suspected malaria cases within 24 hours of symptom
onset by 2005 was reduced by the Ghana Health Services
to 55% in 2007, this goal has not been achieved, and the
question remains as to how this will be achieved.
Improved access to IPTC especially in communities with
no health facilities is one way to reduce the prevalence of
infection and associated morbidity. IPTC studies were car-
ried out in areas with seasonal malaria transmission and
were found to be effective [9,12], but the question is will
it be effective in areas with perennial malaria transmis-
sion, especially when combined with timely home man-
agement? This study was designed to test the potential of
a strategy of IPTC delivered at home and timely treatment
of febrile illness to reduce parasite prevalence and malaria
morbidity in children under five years of age, in rural
coastal Ghana.
Objectives
The goal of this study was to demonstrate the feasibility of
controlling febrile malaria illness at the community level
through combined interventions of intermittent preven-
tive treatment and timely febrile malaria illness manage-
ment in children between six and 60 months of age in
southern Ghana. Specifically, the study was designed to:
deliver intermittent preventive treatment to children
(IPTC) at home and to provide timely treatment for




The study was conducted at Shime sub-district of the Keta
district in the Volta region of Ghana where malaria
accounts for over 40% outpatient clinic attendance in the
district (District Annual Report, 2006). The malaria situa-
tion in the district is perennial with higher transmission
occurring in March (the beginning of the raining season)
to November (the end of the raining season). The Shime
sub-district is one of the four administrative sub-districts
recognized by the Ghana Health Service in the Keta Dis-
trict. It is the most deprived area in the Keta district. Elec-
tricity supply is limited; it has no secondary school and a
very poor road network. During the rainy season most
parts of the area are cut off from the rest of the district. The
land is marshy and covered with streams, lagoons and
creeks. The entire sub-district has a population of 19,972.
The study took place in an area with a population of
8,000. About 99% are Anlo-ewe-speaking people. Their
main occupation is farming and fishing.
The sub-district is served by two health centers and one of
them is located within the study area. Almost all the com-
munities in the area have pipe-borne water, but because of
the 'cash and carry system' where residents pay for every
bucket of water fetched at the point of fetching, the people
continue to use unsafe water from the many water bodies
around to complement the safe one. Four out of the 36
communities in the sub-district participated in the study,
mainly because of geographical accessibility.Malaria Journal 2009, 8:292 http://www.malariajournal.com/content/8/1/292
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Study participants
Community entry activities, involving meetings and dur-
bars of chiefs and people in the study communities, were
done at the onset of the project. After gaining the support
and willingness of the chiefs and people to participate in
the study, the community registers of eligible children
aged ≤60 months were updated. After obtaining consent
from caretakers/parents, children aged six to 60 months
were enrolled in the study. No caretaker refused to partic-
ipate. All children (six to 60 months old), including those
on antiretroviral treatment, were included in the study.
Questionnaire survey
All caretakers of children selected to participate in the
baseline parasite survey were selected as respondents in a
semi-structured questionnaire interview. The question-
naire was designed to solicit information on the demogra-
phy of caretakers, all cause mortality, morbidity, bed net
usage among others. This short interview guide was trans-
lated into the local language and back translated into Eng-
lish to ensure that they convey the meanings they were
intended to. The questionnaire was pre-tested in a field
situation in a community with similar characteristics as
the study community. The interview was conducted in the
local Ewe language by the first author.
Intermittent preventive treatment for children
IPTC was delivered every four months beginning in July
2007 for one year (July, November 2007 and March
2008) and the strategy was evaluated in July, four months
after the last round of IPTC and just before the fifth round
of IPTC. Children received 10 mg/kg body weight of amo-
diaquine (AQ) daily and 4 mg/kg of artesunate (AS) daily
(given as a single dose) over three days. All treatments
were given under direct observation and children were
observed for five minutes after drug administration to
ensure that they retained the medication. Children who
vomited within the five-minute observation period
received a repeated full dose of the medication. Children
were followed up on days 1, 2, 3 and 7 after treatment (the
day of first dose (treatment) was counted as Day 0) to doc-
ument adverse events reported by caretakers using the
adverse report form.
Timely treatment of suspected febrile malaria in children
Any child with febrile illness suspected to be malaria by
the caretaker was reported to the fieldworkers who then
evaluated and treated those who met the protocol criteria
for suspected febrile malaria illness. Those who did not
meet the criteria were referred to the health post located
within the sub-district for further evaluation and treat-
ment. In short, any child with axillary temperature of
≥37.5 degree Celsius, whose caretaker suspected febrile
malaria illness, was treated with the full three-day course
of artesunate and amodiaquine.
Laboratory methods
A diagnosis of malaria infection was made by light micro-
scopy of thick and thin blood smears. Finger print periph-
eral blood was taken by trained technologists from the
Noguchi Memorial Institute for Medical Research for the
preparation of the thick and thin blood smears. All speci-
mens were taken from the field. The thick and thin blood
smears were stained with 3% Giemsa for 30 minutes. Par-
asite density was determined by counting the number of
asexual parasites per 200 white blood cells, and calculated
per μL assuming a white blood cell count of 8,000 cells
per μL. Sexual parasite count was done per 1,000 white
blood cells. A smear was declared negative when the
examination of 100 thick-film fields did not reveal the
presence of asexual parasites. Quality control was done by
allowing a second microscopist to read a random 10%
sample of both negative and positive slides to confirm the
absence or presence of parasites. Discrepant results were
read by a 3rd microscopist and the majority result was
taken as the final result. Haemoglobin concentration was
determined from finger pricks using a portable automated
Hemocue® photometer (Leo Diagnostics, Sweden) at the
field site.
Sample size
Every qualified person living in the study community was
enrolled with the consent of his or her caretaker, mostly
parents. However, for the prevalence survey, a sample size
of 174 was needed to determine malaria parasite preva-
lence estimated at 20% in the study population. Also, to
be able to determine at least10% reduction in malaria par-
asite prevalence in the study population at evaluation, we
needed to enrol about 360 children into the IPTC inter-
vention programme [13]. At evaluation however, after
examining 174 children, randomly selected, and detecting
very low parasite prevalence, all available participants at
the time of the evaluation were examined. This led to the
examination of over 80% of the children enrolled into the
study.
Data analysis
Data were analysed to compare pre-intervention findings
with post-intervention findings. All quantitative analyses
were done using EpiInfo version 3.4.1. Proportions of pre-
and post-intervention clinical findings and parasite levels
were compared using Mann-Whitney or chi-squared tests.
Statistical significance was set at p ≥ 0.05.
Results
Caretakers' interviews
The mean (± SD) age of respondents was 28.2 (± 7.5)
years. Most, (71.0%) of respondents were married. The
mean (± SD) years of formal education was 3.9 (± 3.6)
ranging from 0 to 12 years. However, 37.1% of respond-
ents had no formal education.Malaria Journal 2009, 8:292 http://www.malariajournal.com/content/8/1/292
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Respondents (98.0% for baseline and 100% at evalua-
tion) reported that they and their families usually sleep
under bed net. Comparatively, the number of insecticide-
treated net usage has increased significantly from 38.5%
to 60.0% in the study community within one year of
project implementation. This was as a result of continual
information provided by community assistants to caretak-
ers that treated bed net was an effective way to reduce
febrile malaria illness, and also participants were encour-
aged to take advantage of a highly subsidized treated bed
net provision programme available at the health facility
for children under five years of age and pregnant women.
All respondents (baseline and evaluation) said it was
important for children under five years to sleep under bed
nets.
The mortality data generated was too small to make any
meaningful analysis, but it is important to report that, at
baseline, five (3.0%) caretakers reported that they had lost
a child within the 12 months preceding the interview. The
conditions that killed these children were reported as Asra
- febrile malaria (2), convulsion (1), swelled up (1) and
could not tell (1). Also, 35 (20.1%) respondents said they
knew a close relative who had lost a child less than five
years of age within the past 12 months at baseline. No
caretaker, however, had lost a child or had a relative that
had lost a child in the twelve months of project imple-
mentation.
Parasite prevalence and haemoglobin surveys
During the prevalence surveys (baseline and evaluation) a
number of febrile illnesses were reported for the children
(within the seven days prior to data collection) (Table 1).
On the day of examination, 42% (baseline) and 7.6%
(evaluation) of caretakers reported that the children had
fever within the past seven days, an approximate reduc-
tion of 80% in the point prevalence of fever cases in the
study community (p < 0.00, Mann-Whitney test).
At baseline, five (2.9%) caretakers reported that the chil-
dren were treated for febrile malaria within the seven days
prior to data collection. These five were reportedly treated
with anti-malarials, such as chloroquine, malaherb (local
herbal-based anti-malarial preparation) and Kinaquine®
(a locally-manufactured brand of chloroquine). None of
these five children were taken to the clinic/hospital. On
the other hand, during the evaluation, only two caretakers
reported that their children had been treated within the
seven days prior to data collection and they were treated
by the community assistants working with the project
using amodiaquine and artesunate. However, community
assistants' have referred a total of 29 children whose con-
ditions they suspected not to be febrile malaria-related-
mostly children having running nose/catarrh, stomach
problems, ear infections, eye problems, watery diarrhoea
and fast breathing among others, to the health post
(clinic) for further investigations and treatment within the
12 months of study implementation.
Parasite prevalence
Out of 174 children tested for malaria parasites at base-
line, 44 (25%) of them were positive for malaria parasite
compared with only 10 (3%) out of 357, a significant dif-
ference of over 80% (p < 0.00, Mann-Whitney test). All
the positive infections were P. falciparum, the dominant
species in Ghana. Detailed clinical and parasitological
findings are presented in Table 2. One child (evaluation)
with a very high parasite density was found to have been
taken out of the study community after receiving the first
IPTC and brought back to the community a few days
before the evaluation survey.
Anaemia
In this study, anaemia was defined as haemoglobin < 10
g/dl. There was a significant drop of anaemia in the study
population one year into the intervention (p < 0.004,
Mann-Whitney test), at baseline, 27.6% of the children
were anaemic compared to 16.8% recorded during evalu-
ation (table 2).
There was no relationship between gender and anaemia in
the study population. There was a significant relationship
between reported fever in the seven days prior to baseline
survey and anaemia (X2 = 5.5309, p = 0.01), but this was
Table 1: The distribution of febrile illnesses reported for children within the past seven days prior to the baseline and evaluation 
prevalence surveys. **
Variables Baseline (N = 174) Evaluation (N = 357)
Chills and Rigors 18 (10.3) 13 (3.6)*
Convulsions 4 (2.3) 0*
Diarrhoea 32 (18.4) 15 (4.2)*
Fever/Malaria/Asra 73 (42.0) 27 (7.6)*
Headache 58 (33.3) 18 (5.0)*
Others (Cough, Rashes, Stomach ache etc.) 20 (11.5) 8 (2.2)*
Vomiting 20 (11.5) 11 (3.1)*
** Sorted in column 1 in alphabetical order.
* P. value < 0.00Malaria Journal 2009, 8:292 http://www.malariajournal.com/content/8/1/292
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not the case at evaluation. Also, at baseline there was a sig-
nificant relationship between parasitaemia and anaemia
(X2 = 5.2028, p = 0.02), but this was not the case at evalu-
ation. There was a significant relationship between febrile
status and anaemia at evaluation (P = 0.01 (Fisher exact
test)), but this was not the case at baseline.
There was a significant relationship between febrile status
and parasitaemia at both baseline and evaluation (X2 =
49. 3643, p = < 0.00 - baseline; p = < 0.00 (Fisher exact
test)) - evaluation). There was no gender difference in par-
asitaemia in the study population.
Intermittent preventive treatment for children (IPTC)
IPTC was delivered to children aged six to 60 months in
the study community three times (July and November
2007 and March 2008). There have been marginal
increases in the number of children at each subsequent
treatment round (IPTC1 = 413, IPTC2 = 420 and IPTC3 =
433) (Table 3). Only 22 and 18 children have received
IPTC twice and once respectively at the time of evaluation.
This was due largely to the movement of these children
out of the study community. However, the number of
those who received IPTC once or twice was too small that
we could not perform any meaningful comparative analy-
sis between them and those who received IPTC for three
times.
During each IPTC round, a number of febrile illnesses
were reported by caretakers within the past seven days
prior to treatment (Table 3). On the day of treatment
15.50% (IPTC1), 10.20% (IPTC2) and 2.50% (IPTC3)
respectively of caretakers reported that the children have
had fever within the past seven days. This shows a steady
drop in fever cases in the study community at each subse-
quent treatment.
There was virtually no serious adverse event reported after
drug administrations. However, 5 (1.21%) IPTC1, 4
(0.95%) IPTC2 and 7 (1.65%) IPTC3, caretakers reported
that their children were weak for about two to four hours
after taking the drugs. None of these cases warranted any
medical intervention.
Only five (1.2%) febrile malaria-related illnesses were
treated in the study communities between IPTC1 and
IPTC2, while 39 (9.3) were treated between IPTC2 and
IPTC3 and 17 (3.9%) were treated between IPTC3 and
evaluation.
Informal information, education and communication
Throughout the 12-month intervention period, commu-
nity assistants continued to informally advice community
members on the importance of IPTC, the need for timely
treatment of suspected febrile malaria illness in children
Table 2: Baseline and Evaluation Characteristics, Clinical and Parasitological findings
Variables Baseline (N = 174) Evaluation (N = 357)
Mean age in months (± std.) 30.5 (16.5) months 37.7 (15.8) months
Sex (% of female) 52.3 47.0
Weight: Mean (± std.) 12.3 (3.5) 13.8 (3.5)
Haemoglobin < 10 g/dl 48 (27.6) 60 (16.8)
Number (%) febrile (axillary temp ≥ 37.5°C) 24 (13.8) 8 (2.2)
Parasite prevalence number (%) 44 (25.3%) 10 (3.0)
Geometric mean parasite density 235.30 306.33)
Minimum (maximum) pasitaemia level 30 (900) 30 (29820)
± std. = standard deviation
Table 3: The distribution of febrile illnesses reported for children within the past seven days prior to each drug administration. **
Febrile illness reported in the past seven days prior to drug 
administration
IPTC1 (N = 413) IPTC2 (N = 420) IPTC3 (N = 433)
Number (%) Number (%) Number (%)
Fever/Malaria/Asra 64 (15.50) 43 (10.20) 11 (2.5)
Headache 49 (11.90) 39 (9.30) 5 (1.2)
Vomiting 25 (6.10) 11 (2.60) 1 (0.2)
Chills and Rigors 17 (4.10) 10 (2.40) 7 (1.6)
Others (Cough, Rashes, Stomach ache etc. 7 (1.70) 5 (1.20) 9 (2.1)
Convulsions 5 (1.20) 0 0
Diarrhoea 5 (1.20) 1 (0.20) 3 (0.7)
** Sorted in column 2 in descending order.Malaria Journal 2009, 8:292 http://www.malariajournal.com/content/8/1/292
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within 24 hours of the onset of symptoms and the need to
replace the predominantly untreated bed nets with treated
ones. Community members were encouraged to take
advantage of the highly subsidized treated bed nets avail-
able at the health centre for children under five years and
pregnant women. Pregnant women were also encouraged
and in some cases assisted to attend antenatal clinics.
Feasibility of combining IPTC and timely home 
management for malaria control
The study clearly demonstrates that it is possible to train
community assistants to deliver IPTC and timely home
treatment to children aged six to 60 months. Visits were
made to the community twice in a month to collect timely
home treatment forms. However, during each IPTC
rounds, the first author spent three days in the community
to supervise the research assistants.
Discussion
This study looked at the effectiveness of intermittent pre-
ventive treatment for children (IPTC) combined with
timely treatment at home for malaria control, targeting
children aged six to 60 months old in an all year round
malaria endemic area in Ghana. The main finding of the
study was a reduction of about 88.0% in the prevalence of
malaria parasite infections in the target population (from
25.0% at baseline to 3.0% at evaluation) within one year
of the project implementation. It may be argued that the
increase in the use of insecticide treated net (from 38.5%
to 60.0%) could be implicated in the reduction of the
malaria parasite prevalence in the study population. How-
ever, it is unlikely that all the reduction of over 80.0% was
due to the 55.8% increase in ITN use alone. Several stud-
ies in IPT intervention measured clinical incidence rather
than prevalence and found between 20% and 86.0%
reduction with strong variations depending on transmis-
sion duration and intensity, target population and inter-
vals between treatments [9-12,14,15]. In this study,
prevalence was measured because it is easier to measure as
the interventions were delivered by community assistants.
The second reason for measuring prevalence was the com-
bination of IPTC with home treatment, which requires
that suspected cases were treated once they meet the inclu-
sion criteria and for ethical reasons, the community assist-
ants were not trained to take blood for examination
before treating the children. However, this may be seen as
a weakness of the study.
Anaemia in the children, defined as haemoglobin <10 g/
dl, improved from 27.6% to 16.8%, 12 months after the
intervention was implemented. This compares well with a
recent randomized trial in Tanzania, which showed that
IPT given to infants at the time of childhood immuniza-
tion reduced the incidence of the first episode of malaria
and anaemia by more than 50.0% during the first year of
life [10,11].
There was a noticeable reduction in malaria-related mor-
bidity in the study population as expressed by fever and
other malaria-related signs and symptoms reported either
in the seven days before prevalence surveys or IPTC
administration. The reduction could also be seen from
reported treatment sought for the children within the
seven days prior to prevalence surveys or IPTC administra-
tion. Timely treatment of febrile malaria cases in the com-
munity did not follow any pattern as can be seen from the
result. However, it could be argued that because the com-
munity assistants were on hand to deliver effective treat-
ment in a timely fashion, this could have contributed to
the marked reduction of parasitaemia seen at the evalua-
tion survey. The community assistants also contributed to
heightened health information in the study community
through informal education on the use of treated bed net
and timely treatment. This should encourage malaria con-
trol programmes to have confidence in community assist-
ants to deliver timely treatment and IPTC to children at
the community level, once they are well trained by the
programme coupled with reference manual for easy and
quick referencing when in doubt.
Findings reported here present a challenge to the existing
practice, especially in most sub-Saharan African countries,
where malaria diagnosis is based on presumption without
confirmation. As community intervention or treatment
increases, this may lead to fewer malaria infections and
this may lead to over diagnosis and treatment with expen-
sive drugs for people who do not need them. When this
happened, control programmes would have to invest in
rapid diagnostic test kits where microscopy is not possi-
ble. As reported by Zikusooka et al [16], this may lead to
cost savings because anti-malarial drugs are expensive.
Goodman et al [17] also make this point. Furthermore,
rational use of anti-malarials will reduce the potential for
adverse reactions.
The sharp increases in the number of febrile malaria cases
treated at home between IPTC2 and IPTC3 might have
been largely due to increased confidence of caretakers in
the ability of community assistants to treat their children
with suspected febrile malaria effectively and the recogni-
tion of caretakers of the importance of timely treatment.
The decrease in the numbers between IPTC3 and evalua-
tion could be attributed to the reduction of malaria prev-
alence in the study community as a result of the
interventions implemented.
The use of IPTi which is similar to IPTC in principle was
found to reduce malaria incidence in infants [10].
Although this study cannot determine the contribution of
IPTC and timely treatment at home to the protection
offered to the children because the two interventions were
delivered concurrently, the two together in this studyPublish with BioMed Central    and   every 
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offered a major protection against malaria in children,
reducing prevalence from 25% to 3%.
The results indicate that it is possible to deliver IPTC and
timely home treatment to children between six and 60
months old. Since there were no timely treatment form to
collect at some of the biweekly visits to the community, it
should be possible to reduce the visit to once in a month
to reduce supervision cost.
This indicates that, it is possible to reduce malaria preva-
lence and this may reduce malaria-related childhood mor-
bidity and mortality and this should be explored by
control programme managers as one of the effective
options available for the fight against malaria, especially
in sub-Saharan Africa.
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